HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

O Ilhan Selected Research

Intracranial Hemorrhages (Intracranial Hemorrhage)

1/2001Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


O Ilhan Research Topics

Disease

3Hematologic Neoplasms (Hematological Malignancy)
03/2001 - 04/2000
2Lymphoma (Lymphomas)
12/2009 - 11/2004
2Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2004 - 10/2000
2Breast Neoplasms (Breast Cancer)
05/2003 - 04/2000
2Acute Promyelocytic Leukemia
01/2002 - 10/2001
2Mucositis
03/2001 - 04/2000
2Aplastic Anemia (Anemia, Hypoplastic)
02/2001 - 01/2001
2Neoplasms (Cancer)
01/2001 - 04/2000
1Bronchiolitis Obliterans Syndrome
02/2019
1Mycosis Fungoides
11/2017
1Neutropenia
12/2009
1Multiple Myeloma
12/2009
1Disease Progression
07/2009
1Genetic Translocation (Chromosomal Translocation)
06/2007
1Ulcer
12/2005
1Retinal Vein Occlusion
01/2005
1Macular Edema
01/2005
1Hodgkin Disease (Hodgkin's Disease)
11/2004
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2003
1Fever (Fevers)
02/2002
1Diplopia (Double Vision)
01/2002
1Paralysis (Palsy)
01/2002
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2002
1Abducens Nerve Diseases (Sixth Nerve Palsy)
01/2002
1Graft vs Host Disease (Graft-Versus-Host Disease)
02/2001
1Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2001
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2000
1Leukemia
06/2000
1Myeloproliferative Disorders (Myeloproliferative Disorder)
06/2000
1Hemolytic-Uremic Syndrome
06/2000
1Nausea
06/2000
1Nervous System Diseases (Neurological Disorders)
06/2000
1Paresthesia (Dysesthesia)
06/2000
1Chills
06/2000
1Tremor (Tremors)
06/2000
1Thrombotic Thrombocytopenic Purpura
06/2000
1Colitis
04/2000

Drug/Important Bio-Agent (IBA)

3Melphalan (Alkeran)FDA LinkGeneric
11/2004 - 04/2000
3Carboplatin (JM8)FDA LinkGeneric
11/2004 - 04/2000
3Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
11/2004 - 04/2000
1SteroidsIBA
02/2019
1Etoposide (VP 16)FDA LinkGeneric
12/2009
1Imatinib Mesylate (Gleevec)FDA Link
07/2009
1Transcription Factors (Transcription Factor)IBA
06/2007
1Oxidoreductases (Dehydrogenase)IBA
12/2005
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
01/2005
1Triamcinolone (Aristocort)FDA Link
01/2005
1Retinaldehyde (Retinal)IBA
01/2005
1Interferon-alpha (Interferon Alfa)IBA
05/2003
1InterferonsIBA
05/2003
1Anti-Bacterial Agents (Antibiotics)IBA
02/2002
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2002
1Type A Botulinum Toxins (Botox)FDA Link
01/2002
1Rhodamine 123IBA
01/2002
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
03/2001
1Busulfan (Busulfex)FDA Link
01/2001
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2001
1Methotrexate (Mexate)FDA LinkGeneric
01/2001
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2001
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2000
1thiamine triphosphorate (TTP)IBA
06/2000

Therapy/Procedure

4Drug Therapy (Chemotherapy)
11/2017 - 04/2000
4Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
11/2004 - 04/2000
3Therapeutics
12/2005 - 10/2000
3Stem Cell Transplantation
05/2003 - 10/2001
2Photopheresis
02/2019 - 11/2017
2Blood Component Removal (Apheresis)
12/2009 - 06/2000
2Transplantation
05/2003 - 03/2001
2Platelet Transfusion (Blood Platelet Transfusions)
02/2002 - 01/2001
1Hematopoietic Stem Cell Transplantation
02/2019
1Lasers (Laser)
01/2005
1Total Parenteral Nutrition
02/2002
1Induction Chemotherapy
01/2002
1Radiotherapy
01/2002
1Cell Transplantation
01/2001
1Plasma Exchange
06/2000